{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:13:00Z","timestamp":1794507180080,"version":"4.9.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.semarthrit.2024.152465","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:59:42Z","timestamp":1716292782000},"page":"152465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8715-259X","authenticated-orcid":false,"given":"Yanjie","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Oon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2024.152465_bib0001","doi-asserted-by":"crossref","first-page":"SI29","DOI":"10.1016\/S0140-6736(97)90026-X","article-title":"The impact of cardiovascular disease on people with diabetes: the potential for prevention","volume":"350","author":"Eastman","year":"1997","journal-title":"Lancet"},{"issue":"8919","key":"10.1016\/j.semarthrit.2024.152465_bib0002","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(94)91405-2","article-title":"Pharmacological treatment of hypertension","volume":"344","author":"Swales","year":"1994","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152465_bib0003","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9430","key":"10.1016\/j.semarthrit.2024.152465_bib0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2024.152465_bib0005","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/ard.2007.071092","article-title":"Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)","volume":"66","author":"Verstappen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"9164","key":"10.1016\/j.semarthrit.2024.152465_bib0006","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group","volume":"353","author":"Mottonen","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0007","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152465_bib0008","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American College of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0009","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/1756-185X.13513","article-title":"2018 update of the APLAR recommendations for treatment of rheumatoid arthritis","volume":"22","author":"Lau","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0011","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2013-205139","article-title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international taskforce","volume":"73","author":"van Vollenhoven","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0012","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","article-title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international Task force","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international Task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0014","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152465_bib0015","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/ard.2004.030924","article-title":"Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial","volume":"64","author":"Fransen","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0016","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2008.106617","article-title":"Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study","volume":"69","author":"Verstappen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152465_bib0017","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/rheumatology\/ker355","article-title":"Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial","volume":"51","author":"van Eijk","year":"2012","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152465_bib0018","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/annrheumdis-2013-203748","article-title":"Comparison of initial versus delayed introduction of a treat-to-target strategy in patients with recent-onset rheumatoid arthritis: results of the T-4 3-year study","volume":"73","author":"Urata","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0019","first-page":"369","article-title":"The separate impact of tight control schemes and disease activity on quality of life in patients with early rheumatoid arthritis: results from the CAMERA trials","volume":"32","author":"Jurgens","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0020","first-page":"831","article-title":"Economic evaluation of a tight-control treatment strategy using an imaging device (hand scan) for monitoring joint inflammation in early rheumatoid arthritis","volume":"33","author":"Nair","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0021","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12891-016-1002-2","article-title":"Effectiveness of a telemonitoring intensive strategy in early rheumatoid arthritis: comparison with the conventional management approach","volume":"17","author":"Salaffi","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0022","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/acr.23294","article-title":"Cluster-Randomized trial of a behavioral intervention to incorporate a treat-to-target approach to care of US patients with rheumatoid arthritis","volume":"70","author":"Harrold","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0023","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/msc.1403","article-title":"A randomized study comparing regular care with a nurse-led clinic based on tight disease activity control and person-centred care in patients with rheumatoid arthritis with moderate\/high disease activity: a 6-month evaluation","volume":"17","author":"Bergsten","year":"2019","journal-title":"Musculoskeletal Care"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-023-03151-2","article-title":"Effectiveness of a treattotarget strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept","volume":"25","author":"Bessette","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152465_bib0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/ard.62.7.624","article-title":"Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: a controlled clinical trial","volume":"62","author":"Fransen","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/ard.2008.097683","article-title":"DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis","volume":"69","author":"Goekoop-Ruiterman","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152465_bib0027","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/rheumatology\/kep407","article-title":"How to improve DAS28 use in daily clinical practice? - a pilot study of a nurse-led intervention","volume":"49","author":"van Hulst","year":"2010","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0028","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2011-200274","article-title":"A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts","volume":"71","author":"Schipper","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152465_bib0029","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/ard.2010.137695","article-title":"Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort","volume":"70","author":"Soubrier","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152465_bib0030","first-page":"108","article-title":"Tight control early rheumatoid arthritis clinic in Hong Kong: a pilot study","volume":"18","author":"Kwok","year":"2012","journal-title":"Hong Kong Med J"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152465_bib0031","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/rheumatology\/ket230","article-title":"GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician","volume":"52","author":"Castrej\u00f3n","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152465_bib0032","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/1471-2474-14-350","article-title":"Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry","volume":"14","author":"Vermeer","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152465_bib0033","first-page":"192","article-title":"Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safer compared to delayed initiation of biologics: a real-world study","volume":"35","author":"Lampropoulos","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"52","key":"10.1016\/j.semarthrit.2024.152465_bib0034","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.3346\/jkms.2018.33.e346","article-title":"Treat-to-Target strategy for Asian patients with early rheumatoid arthritis: result of a multicenter trial in Korea","volume":"33","author":"Song","year":"2018","journal-title":"J Korean Med Sci"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152465_bib0035","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.semarthrit.2018.07.004","article-title":"Treat to target strategy in early rheumatoid arthritis versus routine care-A comparative clinical practice study","volume":"48","author":"Brinkmann","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152465_bib0036","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/acr.23755","article-title":"Adverse events and resource use before and after Treat-to-Target in rheumatoid arthritis: a post hoc analysis of a randomized controlled trial","volume":"71","author":"Solomon","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152465_bib0037","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/annrheumdis-2019-216819","article-title":"Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)","volume":"79","author":"Ramiro","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0038","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-020-02393-8","article-title":"Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry","volume":"23","author":"Nekvindov\u00e1","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152465_bib0039","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1093\/rheumatology\/keaa922","article-title":"Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study","volume":"60","author":"Sugihara","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152465_bib0040","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/ard.2008.090712","article-title":"Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90%remission in a pilot trial","volume":"67","author":"van Tuyl","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152465_bib0041","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/acr.22010","article-title":"Treating to a target in established active rheumatoid arthritis patients receiving a tumor necrosis factor inhibitor: results from a real-world cluster-randomized adalimumab trial","volume":"65","author":"Pope","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0042","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/rheumatology\/keu443","article-title":"Tight control of rheumatoid arthritis in a resource-constrained setting: a randomized controlled study comparing the clinical disease activity index and simplified disease","volume":"54","author":"Hodkinson","year":"2015","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0043","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/annrheumdis-2015-208941","article-title":"Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial","volume":"75","author":"Dale","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152465_bib0044","doi-asserted-by":"crossref","first-page":"i4205","DOI":"10.1136\/bmj.i4205","article-title":"Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial","volume":"354","author":"Haavardsholm","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.semarthrit.2018.05.001","article-title":"Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: an HR-pQCT study","volume":"48","author":"Yue","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152465_bib0046","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1093\/rheumatology\/kez674","article-title":"Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis","volume":"59","author":"Sundin","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152465_bib0047","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000649","article-title":"Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis","volume":"4","author":"Akdemir","year":"2018","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152465_bib0048","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/art.41232","article-title":"Achievement of remission in two early rheumatoid arthritis cohorts implementing different Treat-to-Target strategies","volume":"72","author":"Norvang","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152465_bib0049","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/art.30494","article-title":"Implementation of a Treat-to-Target strategy in very early rheumatoid arthritis. results of the Dutch rheumatoid arthritis monitoring remission induction cohort study","volume":"63","author":"Vermeer","year":"2011","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152465_bib0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10067-010-1583-3","article-title":"Impact of tight control strategy on rheumatoid arthritis in Sarawak","volume":"30","author":"Teh","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152465_bib0051","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/acr.21984","article-title":"Sustained beneficial effects of a protocolized Treat-to-Target strategy in very early rheumatoid arthritis: three-year results of the Dutch rheumatoid arthritis monitoring remission induction cohort","volume":"65","author":"Vermeer","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152465_bib0052","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/rheumatology\/keu395","article-title":"Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE)","volume":"54","author":"Sugihara","year":"2015","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152465_bib0053","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s10067-015-2915-0","article-title":"Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study","volume":"34","author":"Brenol","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0054","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10067-016-3191-3","article-title":"Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry","volume":"35","author":"Steunebrink","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152465_bib0055","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3899\/jrheum.151392","article-title":"Effect of adherence to protocolized targeted intensifications of disease-modifying antirheumatic drugs on treatment outcomes in rheumatoid arthritis: results from an Australian early arthritis cohort","volume":"43","author":"Wabe","year":"2016","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0056","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00296-017-3695-4","article-title":"Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study","volume":"37","author":"de Andrade","year":"2017","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0057","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/annrheumdis-2017-211375","article-title":"Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study","volume":"77","author":"Akdemir","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152465_bib0058","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10067-017-3962-5","article-title":"Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice","volume":"37","author":"Versteeg","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152465_bib0059","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/annrheumdis-2017-212830","article-title":"Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes","volume":"77","author":"Sundliser","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/annrheumdis-2021-220750","article-title":"Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment","volume":"81","author":"Holten","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152465_bib0061","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3899\/jrheum.2022-1176","article-title":"Integrating PROMIS measures in a treat-to-target approach to standardize patient-centered treatment of rheumatoid arthritis","volume":"50","author":"Greene","year":"2023","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152465_bib0062","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1093\/rheumatology\/kead021","article-title":"Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM","volume":"62","author":"Ramiro","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2024.152465_bib0063","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","article-title":"Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial","volume":"386","author":"Coates","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152465_bib0064","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/annrheumdis-2017-211137","article-title":"The dynamics of response as measured by multiple composite outcome tools in the tight control of inflammation in early Psoriatic Arthritis (TICOPA) trial","volume":"76","author":"Coates","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0065","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/acr.23293","article-title":"Cost-effectiveness of tight control of inflammation in early psoriatic arthritis: economic analysis of a multicenter randomized controlled trial","volume":"70","author":"O'dwyer","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152465_bib0066","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2020-219585","article-title":"Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial","volume":"80","author":"Molto","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0067","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/15-234","article-title":"A pharmacist-staffed, virtual gout management clinic for achieving target serum uric acid levels: a randomized clinical trial","volume":"20","author":"Goldfien","year":"2016","journal-title":"Perm J"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152465_bib0068","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2016-210872","article-title":"A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout","volume":"76","author":"Stamp","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152465_bib0069","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/annrheumdis-2017-211873","article-title":"Allopurinol dose escalation to achieve serum urate below 6 mg\/dL: an open-label extension study","volume":"76","author":"Stamp","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10156","key":"10.1016\/j.semarthrit.2024.152465_bib0070","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152465_bib0071","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/art.40929","article-title":"Effects of allopurinol dose escalation on bone erosion and urate volume in gout: a dual-energy computed tomography imaging study within a randomized, controlled trial","volume":"71","author":"Dalbeth","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152465_bib0072","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/EDE.0000000000001608","article-title":"Comparative safety of gout treatment strategies on cardiovascular outcomes using observational data: clone-censor-weight target trial emulation approach","volume":"34","author":"Yoshida","year":"2023","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152465_bib0073","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/acr.23995","article-title":"Comparative study of real-life management strategies in gout: data from two protocolized gout clinics","volume":"72","author":"Kampe","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0074","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study","volume":"72","author":"Rees","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152465_bib0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.semarthrit.2015.05.005","article-title":"An open-label, 6-month study of allopurinol safety in gout: the LASSO study","volume":"45","author":"Becker","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152465_bib0076","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/03009742.2017.1350746","article-title":"Gout in a rheumatology clinic: results of EULAR\/ACR guidelines-compliant treatment","volume":"47","author":"Slot","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152465_bib0077","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/annrheumdis-2020-217392","article-title":"Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study","volume":"79","author":"Hammer","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0078","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13075-022-02772-3","article-title":"Haavardsholm E, Perez\u2011Ruiz F, et al. One\u2011 and 2\u2011year flare rates after treat\u2011to\u2011target and tight\u2011control therapy of gout: results from the NOR\u2011Gout study","volume":"24","author":"Uhlig","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152465_bib0079","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2016-209467","article-title":"Treat-to-target (T2T) recommendations for gout","volume":"76","author":"Kiltz","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152465_bib0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/ard.2009.126748","article-title":"Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis","volume":"69","author":"Knevel","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152465_bib0081","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/annrheumdis-2015-207526","article-title":"Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update","volume":"75","author":"Stoffer","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2024.152465_bib0082","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/rheumatology\/keq195","article-title":"Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome","volume":"49","author":"Schipper","year":"2010","journal-title":"Rheumatology"},{"issue":"71","key":"10.1016\/j.semarthrit.2024.152465_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21710","article-title":"The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis","volume":"21","author":"Wailoo","year":"2017","journal-title":"Health Technol Assess"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:47:28Z","timestamp":1720046848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":83,"alternative-id":["S0049017224001057"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152465","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152465"}}